LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.
Level 5 - mechanism / opinion, no new human data
Bench and laboratory study on human serum and purified proteins without clinical outcome measurement.
PubMed 11160139 · doi:10.1172/JCI10832
What was done
The authors investigated the physical association between lipopolysaccharide-binding protein (LBP) and serum lipoproteins (LDL, VLDL, and HDL) in serum from healthy individuals and septic patients, as well as in vitro with purified apolipoproteins (apoB and apoA-I). They evaluated the distribution of LBP among lipoprotein classes and assessed the role of LBP in facilitating endotoxin (LPS) binding to LDL and VLDL.
What was found
The abstract reports no numerical values, sample sizes, or effect sizes. Qualitatively, LBP circulated bound primarily to apoB-containing LDL and VLDL in healthy serum, mediated partly by apoB. While LBP bound purified apoA-I in vitro, it did not associate with apoA-I or HDL in serum. LBP association with LDL/VLDL enhanced their LPS-binding capacity. In septic serum, despite high LBP levels and altered lipoprotein spectra, LBP and LPS were predominantly associated with LDL and VLDL, with some LBP circulating free.
Why it matters
This study identifies LDL and VLDL as the primary circulating carriers of LBP and demonstrates that LBP-LDL/VLDL complex formation promotes endotoxin binding and scavenging during infection.
Limits
The abstract provides no sample size (n is not reported for healthy or septic groups), no numerical data, and no statistical measures. The findings are based on in vitro and ex vivo serum assays without clinical outcome assessments.
Cited by
- supports LPS binds to LDL and VLDL particles via lipid interactions and binds specifically to the apoB protein.